Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction
Background: To study the impact of MRI characteristics and of targeted biopsy (TB) core number on the final grade group (GG) prediction. Materials and Methods: The cohort was 478 consecutive patients who underwent radical prostatectomy (RP) after positive mpMRI (multiparametric magnetic resonance im...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/1/225 |
id |
doaj-03efe4ef2cd44e128ef421b845e498fd |
---|---|
record_format |
Article |
spelling |
doaj-03efe4ef2cd44e128ef421b845e498fd2020-11-25T01:10:11ZengMDPI AGJournal of Clinical Medicine2077-03832020-01-019122510.3390/jcm9010225jcm9010225Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading PredictionGuillaume Ploussard0Jean-Baptiste Beauval1Raphaële Renard-Penna2Marine Lesourd3Cécile Manceau4Christophe Almeras5Jean-Romain Gautier6Guillaume Loison7Daniel Portalez8Ambroise Salin9Michel Soulié10Christophe Tollon11Bernard Malavaud12Mathieu Roumiguié13Department of Urology, La Croix du Sud Hospital, 52, chemin de Ribaute, 31130 Quint Fonsegrives, FranceDepartment of Urology, La Croix du Sud Hospital, 52, chemin de Ribaute, 31130 Quint Fonsegrives, FranceDepartment of Radiology, CHU La Pitié Salpétrière/Tenon, Sorbonne Université, 75005 Paris, FranceDepartment of Urology, Institut Universitaire du Cancer Toulouse—Oncopole, 31000 Toulouse, FranceDepartment of Urology, CHU Toulouse, 31000 Toulouse, FranceDepartment of Urology, La Croix du Sud Hospital, 52, chemin de Ribaute, 31130 Quint Fonsegrives, FranceDepartment of Urology, La Croix du Sud Hospital, 52, chemin de Ribaute, 31130 Quint Fonsegrives, FranceDepartment of Urology, La Croix du Sud Hospital, 52, chemin de Ribaute, 31130 Quint Fonsegrives, FranceDepartment of Radiology, Institut Universitaire du Cancer Toulouse—Oncopole, 31000 Toulouse, FranceDepartment of Urology, La Croix du Sud Hospital, 52, chemin de Ribaute, 31130 Quint Fonsegrives, FranceDepartment of Urology, CHU Toulouse, 31000 Toulouse, FranceDepartment of Urology, La Croix du Sud Hospital, 52, chemin de Ribaute, 31130 Quint Fonsegrives, FranceDepartment of Urology, Institut Universitaire du Cancer Toulouse—Oncopole, 31000 Toulouse, FranceDepartment of Urology, Institut Universitaire du Cancer Toulouse—Oncopole, 31000 Toulouse, FranceBackground: To study the impact of MRI characteristics and of targeted biopsy (TB) core number on the final grade group (GG) prediction. Materials and Methods: The cohort was 478 consecutive patients who underwent radical prostatectomy (RP) after positive mpMRI (multiparametric magnetic resonance imaging) followed by fusion TB. Endpoints were the upgrading and concordance rates between TB and RP specimens. Results: Upgrading rate after TB was 40.6%. Patients with upgrading had lower PIRADS (Prostate Imaging-Reporting and Data System) scores (<i>p</i> < 0.001), smaller lesion size (<i>p</i> = 0.017), fewer TB cores (<i>p</i> < 0.001), and lower TB density (<i>p</i> = 0.015) compared with cases with grade concordance. There was a significant continuous improvement in upgrading rate when TB core number per lesion increased from 56.3% to 25.6% when <2 or ≥5 TB cores were taken, respectively (<i>p</i> = 0.002). The minimal TB number per lesion to reduce upgrading risk to approximately 30%was 4 in PIRADS 3, and 3 in PIRADS 4−5 cases. Conclusions: Grade group prediction by TB is significantly improved by higher PIRADS score, larger lesion size, and increased TB per lesion. At least four TB cores should be taken in PIRADS 3 score lesions, whereas three cores seem enough in PIRADS 4−5 cases to improve GG prediction and limit upgrading risk.https://www.mdpi.com/2077-0383/9/1/225prostate cancerradical prostatectomyupgradingbiopsytargeted biopsiesmrifusion biopsiessystematic biopsies |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Guillaume Ploussard Jean-Baptiste Beauval Raphaële Renard-Penna Marine Lesourd Cécile Manceau Christophe Almeras Jean-Romain Gautier Guillaume Loison Daniel Portalez Ambroise Salin Michel Soulié Christophe Tollon Bernard Malavaud Mathieu Roumiguié |
spellingShingle |
Guillaume Ploussard Jean-Baptiste Beauval Raphaële Renard-Penna Marine Lesourd Cécile Manceau Christophe Almeras Jean-Romain Gautier Guillaume Loison Daniel Portalez Ambroise Salin Michel Soulié Christophe Tollon Bernard Malavaud Mathieu Roumiguié Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction Journal of Clinical Medicine prostate cancer radical prostatectomy upgrading biopsy targeted biopsies mri fusion biopsies systematic biopsies |
author_facet |
Guillaume Ploussard Jean-Baptiste Beauval Raphaële Renard-Penna Marine Lesourd Cécile Manceau Christophe Almeras Jean-Romain Gautier Guillaume Loison Daniel Portalez Ambroise Salin Michel Soulié Christophe Tollon Bernard Malavaud Mathieu Roumiguié |
author_sort |
Guillaume Ploussard |
title |
Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction |
title_short |
Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction |
title_full |
Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction |
title_fullStr |
Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction |
title_full_unstemmed |
Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction |
title_sort |
assessment of the minimal targeted biopsy core number per mri lesion for improving prostate cancer grading prediction |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2020-01-01 |
description |
Background: To study the impact of MRI characteristics and of targeted biopsy (TB) core number on the final grade group (GG) prediction. Materials and Methods: The cohort was 478 consecutive patients who underwent radical prostatectomy (RP) after positive mpMRI (multiparametric magnetic resonance imaging) followed by fusion TB. Endpoints were the upgrading and concordance rates between TB and RP specimens. Results: Upgrading rate after TB was 40.6%. Patients with upgrading had lower PIRADS (Prostate Imaging-Reporting and Data System) scores (<i>p</i> < 0.001), smaller lesion size (<i>p</i> = 0.017), fewer TB cores (<i>p</i> < 0.001), and lower TB density (<i>p</i> = 0.015) compared with cases with grade concordance. There was a significant continuous improvement in upgrading rate when TB core number per lesion increased from 56.3% to 25.6% when <2 or ≥5 TB cores were taken, respectively (<i>p</i> = 0.002). The minimal TB number per lesion to reduce upgrading risk to approximately 30%was 4 in PIRADS 3, and 3 in PIRADS 4−5 cases. Conclusions: Grade group prediction by TB is significantly improved by higher PIRADS score, larger lesion size, and increased TB per lesion. At least four TB cores should be taken in PIRADS 3 score lesions, whereas three cores seem enough in PIRADS 4−5 cases to improve GG prediction and limit upgrading risk. |
topic |
prostate cancer radical prostatectomy upgrading biopsy targeted biopsies mri fusion biopsies systematic biopsies |
url |
https://www.mdpi.com/2077-0383/9/1/225 |
work_keys_str_mv |
AT guillaumeploussard assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT jeanbaptistebeauval assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT raphaelerenardpenna assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT marinelesourd assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT cecilemanceau assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT christophealmeras assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT jeanromaingautier assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT guillaumeloison assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT danielportalez assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT ambroisesalin assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT michelsoulie assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT christophetollon assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT bernardmalavaud assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction AT mathieuroumiguie assessmentoftheminimaltargetedbiopsycorenumberpermrilesionforimprovingprostatecancergradingprediction |
_version_ |
1725176357249351680 |